October 12, 2023 Experience Genetron $126 million going-private transaction We are separately advising Genetron and the special committee of its board on the transaction
August 24, 2023 Experience Chindata Group going-private transaction We are advising APG on the transaction
August 11, 2023 Experience Lorom merger with In-Tech We advised Cornell Capital and Lorom on the transaction
January 17, 2023 Experience China Resources Beer RMB12.3 billion acquisition of Jinsha Winery We advised China Resources Beer on the acquisition of a controlling interest in Jinsha Winery
January 11, 2023 Experience Sirio Pharma acquisition of a majority stake of Best Formulations We advised Sirio Pharma on the acquisition
September 8, 2022 Experience Tencent €300 million investment in Ubisoft We are advising Tencent on the transaction
August 19, 2022 Experience Esco Aster spinoff transactions We are advising Esco Lifesciences on the spinoff
August 11, 2022 Experience InSilico Medicine $35 million Series D2 financing We are advising InSilico Medicine on the financing
August 3, 2022 Experience Taibang Biologic Group $300 million equity raising We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
June 29, 2022 Experience Tencent renewed strategic cooperation with JD.com We are advising Tencent on the renewal of the strategic cooperation agreement and purchase of ordinary shares of JD.com